ACST

Acasti Pharma Class A (ACST)

About Acasti Pharma Class A (ACST)

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002, and is headquartered in Princeton, NJ.

Details

Daily high

$3.40

Daily low

$3.22

Price at open

$3.29

52 Week High

$3.50

52 Week Low

$3.02

Market cap

34.4M

Dividend yield

0.00%

Volume

6,670

Avg. volume

23,023

P/E ratio

-2.78

Acasti Pharma Class A News